Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMMUNOGAST: Atezolizumab + Ipatasertib or Bevacizumab in Advanced Gastric Adenocarcinoma
NCT04739202Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Mar 2021
- Primary completion
- Jun 2026
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab in gastric adenocarcinoma, sponsored by Hospices Civils de Lyon. Started Mar 2021; status: completed.
02
Drugs
atezolizumab
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT04739202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04739202.